AI assistant
Sending…
Health Catalyst, Inc. — Director's Dealing 2020
Feb 21, 2020
33681_dirs_2020-02-20_c87c4a40-ed72-4317-b789-3af5c0cd417a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2020-02-14
Reporting Person: Bullock D Fraser (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-14 | Common Stock | J | 609143.00 | $0.00 | Disposed | 0.00 | Indirect |
| 2020-02-14 | Common Stock | J | 29482.00 | $0.00 | Acquired | 66271.00 | Direct |
Footnotes
F1: Represents a pro rata distribution for no consideration.
F2: These shares are held directly by HQC Acquisition, LLC. The Reporting Person is the President of HQC Acquisition, LLC and it is controlled by Sorenson Capital Partners. The Reporting Person is a founding member and general partner of Sorenson Capital Partners and disclaims beneficial ownership of these shares held by HQC Acquisition, LLC except to the extent of his pecuniary interest therein.
More from Health Catalyst, Inc.
M&A Activity
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 3
Proxy Solicitation & Information Statement
2026
Jun 3
Interim / Quarterly Report
2026
May 11
Board/Management Information
2026
Apr 27
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27